Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system
暂无分享,去创建一个
[1] Gordon L. Amidon,et al. Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size , 1996, Pharmaceutical Research.
[2] J C Middleton,et al. Synthetic biodegradable polymers as orthopedic devices. , 2000, Biomaterials.
[3] Linbo Wu,et al. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. , 2004, Biomaterials.
[4] M A Tracy,et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. , 1999, Biomaterials.
[5] Michael J. Campolongo,et al. Drug delivery: Old polymer learns new tracts. , 2009, Nature materials.
[6] J. Berg. Interfacial Hydrodynamics: An Over View , 1982 .
[7] Stephanie E. A. Gratton,et al. The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.
[8] G. Lutz,et al. Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides , 2009, Journal of nanobiotechnology.
[9] L. Scriven,et al. Interfacial turbulence: Hydrodynamic instability and the marangoni effect , 1959 .
[10] R. Pandey,et al. Nanoparticle-Based Oral Drug Delivery System for an Injectable Antibiotic – Streptomycin , 2007, Chemotherapy.
[11] Jeremy L. Steinbacher,et al. Interfacial polymerization within a simplified microfluidic device: capturing capsules. , 2005, Journal of the American Chemical Society.
[12] Tejraj M Aminabhavi,et al. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[13] Robert Langer,et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.
[14] J. Siepmann,et al. Mathematical modeling of bioerodible, polymeric drug delivery systems. , 2001, Advanced drug delivery reviews.
[15] M. Shive,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .
[16] J. Benoit,et al. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. , 2003, Biomaterials.
[17] Q. Ping,et al. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies. , 2008, Drug development and industrial pharmacy.
[18] S. Cryan,et al. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. , 2008, International journal of pharmaceutics.
[19] S. Feng,et al. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[20] M. L. La Rotonda,et al. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[21] Fakhrul Ahsan,et al. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses. , 2009, International journal of pharmaceutics.
[22] Robert Langer,et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.
[23] Fernando Albericio,et al. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[24] M. R. Kumar,et al. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] Jinsong Hua,et al. Characterization of electrospraying process for polymeric particle fabrication , 2008 .
[26] J. Benoit,et al. How to achieve sustained and complete protein release from PLGA-based microparticles? , 2008, International journal of pharmaceutics.
[27] Anderson,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.
[28] Robert Gurny,et al. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] H. M. Nielsen,et al. Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation , 2009, Journal of Controlled Release.
[30] M. A. Holgado,et al. Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC. , 2009, International journal of pharmaceutics.
[31] Robert Gurny,et al. Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation. , 2007, International journal of pharmaceutics.
[32] Hatem Fessi,et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .
[33] A. Xu,et al. Recombinant interferon-alpha2b poly(lactic-co-glycolic acid) microspheres: pharmacokinetics-pharmacodynamics study in rhesus monkeys following intramuscular administration , 2008, Acta Pharmacologica Sinica.
[34] T. Fahmy,et al. Controlling the morphology of electrospray-generated PLGA microparticles for drug delivery. , 2010, Journal of colloid and interface science.
[35] Hans P Merkle,et al. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.
[36] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[37] V. Kanchan,et al. Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles. , 2008, Journal of microencapsulation.
[38] S. Vyas,et al. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. , 2006, Vaccine.